Skip to content

A case-control study on the impact of static standing balance function in patients with idiopathic scoliosis

A case-control study on the impact of static standing balance function in patients with idiopathic scoliosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078329
Enrollment
Unknown
Registered
2023-12-05
Start date
2023-12-05
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic scoliosis

Interventions

Case group:None
Control group:None

Sponsors

Zhujaing hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1: Case group:Informed consent of the participants, who voluntarily participate in this study;Age is 10 years or older, right-handed;Diagnosed with idiopathic scoliosis according to the American Radiological Criteria, with a Cobb angle of 10°-45°;Able to understand and follow the study procedures. 2: Control group:Informed consent, voluntary participation in this study;Age = 10 years, right-handed;There was no history of scoliosis; be able to understand and follow the research procedures.

Exclusion criteria

Exclusion criteria: 1: Case group:Vision impairment that cannot be corrected and balanced through the use of visual aids (such as glasses) and balance-related disorders;Existence of other neuromuscular, skeletal muscle system diseases, or relevant past medical history that may affect posture control (such as previous lower limb surgery, Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), Friedreich ataxia (FRDA), Charcot-Marie-Tooth disease (CMT), diabetes, peripheral neuropathy, vestibular disease, arthritis, orthopedic disease, acute infection, malignancy, severe visual or hearing impairment); Existence of diseases affecting brain function, such as central nervous system diseases, mental illness, or cognitive impairment (cerebellar disease, acute cerebrovascular disease, delirium, terminal illness, mental illness);Existence of diseases affecting brain function, such as central nervous system diseases, mental illness, or cognitive impairment (cerebellar disease, acute cerebrovascular disease, delirium, terminal illness, mental illness); Recent receipt of spine surgery or other treatments that may affect study results; Other conditions that the investigator determines are not suitable for enrollment. 2: Control group:Vision impairment that cannot be corrected and balanced through the use of visual aids (such as glasses) and balance-related disorders; Existence of other neuromuscular, skeletal muscle system diseases, or relevant past medical history that may affect posture control (such as previous lower limb surgery, Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), Friedreich ataxia (FRDA), Charcot-Marie-Tooth disease (CMT), diabetes, peripheral neuropathy, vestibular disease, arthritis, orthopedic disease, acute infection, malignancy, severe visual or hearing impairment); Existence of diseases affecting brain function, such as central nervous system diseases, mental illness, or cognitive impairment (cerebellar disease, acute cerebrovascular disease, delirium, terminal illness, mental illness); Existence of diseases affecting brain function, such as central nervous system diseases, mental illness, or cognitive impairment (cerebellar disease, acute cerebrovascular disease, delirium, terminal illness, mental illness); Recent receipt of spine surgery or other treatments that may affect study results; Other conditions that the investigator determines are not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Romberg rate;

Secondary

MeasureTime frame
Change in oxyhemoglobin;

Countries

China

Contacts

Public ContactGuozhi Huang

Zhujiang hospital,Southern Medical University

2287109280@qq.com+86 151 1327 2135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026